Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum]
Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087–2094.On page 2089, a column heading in Table 1 was incorrectly presented. The last column heading was presented as “Golimumab 60 mg”, whereas this should have been presented as “Golimu...
Saved in:
Main Authors: | Toussirot E (Author), Vauchy C (Author), Binda D (Author), Michel F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
by: Toussirot E, et al.
Published: (2016) -
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
by: Paccou J, et al.
Published: (2016) -
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
by: Eric Toussirot
Published: (2022) -
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013) -
Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis
by: I. Olivieri, et al.
Published: (2013)